Valuation APTOCROM Inc.

Stocks

End-of-day quote Korea S.E. Other stock markets 03/07/2026			5-day change	1st Jan Change
1,714.00 ^KRW	-0.98%		+1.30%	-65.72%

07-01	Aprogen Biologics Inc. announced that it has received KRW 50.8 billion in funding from APTOCROM Inc.	CI
05-26	Aprogen Biologics Inc. announced that it expects to receive KRW 50.8 billion in funding from APTOCROM Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	132,471	125,151	66,950	51,548	104,593	55,189
Change	-	-5.53%	-46.5%	-23.01%	102.9%	-47.23%
Enterprise Value (EV) ¹	101,306	69,004	-14,380	55,057	79,526	37,996
Change	-	-31.89%	-120.84%	482.87%	44.44%	-52.22%
P/E	12x	47.2x	-11.9x	24x	-2.12x	-9.5x
PBR	0.57x	0.56x	0.34x	0.31x	0.35x	0.18x
PEG	-	-0.6x	0x	-0x	0x	0.1x
Capitalization / Revenue	12.8x	14.9x	6.98x	3.22x	6.38x	5.63x
EV / Revenue	9.82x	8.2x	-1.5x	3.44x	4.85x	3.87x
EV / EBITDA	4,671x	-31.8x	1.22x	-2.69x	83.9x	-2.32x
EV / EBIT	-270x	-26.8x	1.19x	-2.62x	154x	-2.27x
EV / FCF	-1.98x	5.77x	-0.46x	13.1x	-32.9x	-1.9x
FCF Yield	-50.6%	17.3%	-216%	7.65%	-3.04%	-52.7%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	6,200	1,484	-3,140	648.5	-4,924	-526.5
Distribution rate	-	-	-	-	-	-
Net sales ¹	10,319	8,416	9,598	16,007	16,400	9,807
EBITDA ¹	21.69	-2,167	-11,810	-20,454	947.7	-16,372
EBIT ¹	-375.2	-2,579	-12,099	-21,004	517.3	-16,737
Net income ¹	11,084	2,650	-5,607	4,304	-28,094	-5,559
Net Debt ¹	-31,165	-56,147	-81,330	3,509	-25,067	-17,192
Reference price ²	74,200.00	70,100.00	37,500.00	15,580.00	10,420.00	5,000.00
Nbr of stocks (in thousands)	1,785	1,785	1,785	3,309	10,038	11,038
Announcement Date	15/03/21	14/03/22	17/03/23	13/03/24	14/03/25	20/03/26

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
APTOCROM INC.	-	-	-	-	12.36M
ELI LILLY AND COMPANY	35.49x	12.89x	26.26x	0.56%	1,082B
JOHNSON & JOHNSON	28.11x	6.46x	17.57x	2.03%	633B
ABBVIE INC.	32.2x	7.69x	15.73x	2.65%	461B
ROCHE HOLDING AG	18.15x	4.51x	11.08x	2.94%	338B
ASTRAZENECA PLC	24.06x	5.03x	14.1x	1.73%	299B
NOVARTIS AG	22.19x	5.69x	13.74x	2.76%	291B
NOVO NORDISK A/S	14.43x	5.37x	11.03x	3.47%	222B
AMGEN INC.	24.39x	6.45x	11.36x	2.7%	202B
GILEAD SCIENCES, INC.	-46.87x	5.66x	31.47x	2.47%	163B
Average	16.90x	6.64x	16.92x	2.37%	369.24B
Weighted average by Cap.	24.74x	8.04x	18.59x	1.94%